Pancreatic Resectability in Cancers With Known Limited Extension (PRICKLE)

NCT02124369 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Poor accrual

Conditions

Pancreatic Adenocarcinoma

Interventions

DRUG: Abraxane
DRUG: Gemcitabine

Sponsor

CCTU- Cancer Theme

Collaborators

[object Object]
[object Object]
[object Object]